Skip to search formSkip to main contentSkip to account menu

Budesonide 3 MG Delayed Release Oral Capsule

Known as: BUDESONIDE 3 mg ORAL CAPSULE [Budesonide], BUDESONIDE 3 mg ORAL CAPSULE, BUDESONIDE 3 mg ORAL CAPSULE, DELAYED RELEASE PELLETS [Budesonide (Enteric Coated)] 
National Institutes of Health

Related topics

Related topics

46 relations
2-acetyltributylcitrateAcetic AcidAcute DiseaseAmmonia

Narrower (1)

Budesonide 3 MG Delayed Release Oral Capsule [Entocort]

Broader (2)

Budesonide Oral ProductGlucocorticoids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study
BackgroundTo evaluate barrier protective properties of Rhinosectan® spray, a medical device containing xyloglucan, on nasal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)